Autoimmune hepatitis

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Monoclonal antibody 1 substance
Phase II/III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II/III

1 trial
  • Novartis Pharma AG Commercial
    IANALUMAB
    2023-508859-39-00 2 countries 2018 n=7
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Novartis Pharma AG Commercial 1 Phase II/III 0
← All indication landscapes